FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/09/2026
Back to search
Official data from USPTO
PRUFIBRY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/10/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
04/12/2024
Registration date
09/02/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/02/2025
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
DE
Examiner
PARKER, JUSTINE D
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Biotest AG
Representatives
Garth M. Dahlen Mendelsohn Dunleavy, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for use in industry and sciencenamely proteins and protein preparations derived from human bloodblood plasmablood serumcoagulation factors; biological preparationsnamely plasma and serum preparations for cultivating cellstissueorgans for industrial and scientific purposes.
Class 5
Pharmaceuticalmedical and veterinary preparations for hematologyfor intensive care medicinefor transplantation medicinefor oncologyfor influencing blood diseasesfor influencing blood coagulation; blood productsblood substituteblood plasma substitute for medical purposes; blood serums preparations for medical purposesin particular those containing serum proteins and related solutions; pharmaceutical proteins and medical protein preparations made from human bloodblood plasma and blood serum for hematologyfor intensive care medicinefor transplantation medicinefor oncologyfor influencing blood diseasesfor influencing blood coagulation; pharmaceutical preparations in the nature of human coagulation factors for hematologyfor intensive care medicinefor transplantation medicinefor the treatment of oncologyfor influencing blood diseasesfor influencing blood coagulation; fibrinogen and fibrinogen made from human blood plasmain the nature of pharmaceutical preparations for hematologyfor intensive care medicinefor transplantation medicinefor the treatment of oncologyfor influencing blood diseasesfor influencing blood coagulation; pharmaceutical and veterinary products for hematologyintensive care medicinetransplantation medicineoncologyfor influencing blood diseasesfor influencing blood coagulation
Publications
History of USPTO decisions and trademark events.
34 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/26/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/19/2026
FIMP
FINAL DISPOSITION PROCESSED
03/19/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/09/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/09/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/15/2025
PUBO
PUBLISHED FOR OPPOSITION
07/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
06/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
06/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/17/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/17/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/17/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/17/2025
RFNT
REFUSAL PROCESSED BY IB
11/17/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/30/2024
RFRR
REFUSAL PROCESSED BY MPU
10/30/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/25/2024
CNRT
NON-FINAL ACTION WRITTEN
10/24/2024
DOCK
ASSIGNED TO EXAMINER
10/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/10/2024
Continuous trademark protection
Get notified about every new filing that threatens PRUFIBRY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.